Skip to content
ethotoin

Structure via PubChem · Public domain (PubChem)

EntityQ4533122· pop 7· linked from 401 articles

Also known as Peganone®, 3-ethyl-5-phenyl-2,4-imidazolidinedione, 1-ethyl-2,5-dioxo-4-phenylimidazolidine, 3-ethyl-5-phenylhydantoin, (+-)-3-ethyl-5-phenylhydantoin, 3-ethyl-5-phenylimidazolidin-2,4-dione, 1-Ethyl-2,5-dioxo-4-phenylimidazolidine, 3-Ethyl-5-phenyl-2,4-imidazolidinedione

Ethotoin (previously marketed as Peganone) is an anticonvulsant drug used in the treatment of epilepsy. It is a hydantoin, similar to phenytoin. It is not available in the United States.

Chemical data

Formula
C11H12N2O2
Molecular weight
204.22 g/mol
IUPAC name
3-ethyl-5-phenylimidazolidine-2,4-dione
SMILES
CCN1C(=O)C(NC1=O)C2=CC=CC=C2
InChIKey
SZQIFWWUIBRPBZ-UHFFFAOYSA-N
XLogP
1
Polar surface area
49.4 Ų
H-bond donors
1
H-bond acceptors
2
Formal charge
0

via PubChem

Drug data · ChEMBL

Max clinical phase
Approved
Molecule type
Small molecule
First approval
1957
Admin. routes
oral
Indications
epilepsy, Seizure

via ChEMBL · EBI

Research

48 papers

via PubMed

Wikidata facts

Mass
204.09
Has use
medication
Show 7 more facts
chemical formula
C₁₁H₁₂N₂O₂
subject has role
anticonvulsant agent
medical condition treated
epilepsy
World Health Organisation international non-proprietary name
ethotoin
canonical SMILES
CCN1C(=O)C(NC1=O)C2=CC=CC=C2
defined daily dose
2.5
Commons category
Ethotoin
Sources (5)

via Wikidata · CC0

~2 min read

Encyclopedic overview

7 sections
Contents
  • Mechanism of action
  • Approval history
  • Indications and usage
  • Dosing
  • Side effects
  • Chemistry
  • References

Ethotoin (previously marketed as Peganone) is an anticonvulsant drug used in the treatment of epilepsy. It is a hydantoin, similar to phenytoin. It is not available in the United States.

==Mechanism of action== The mechanism of action of ethotoin is similar to that of phenytoin.

Excerpted from Wikipedia’s “ethotoin” article, available under the CC BY-SA 4.0 licence.

Available in 6 languages

via Wikidata sitelinks · CC0